Atropine does not cross the blood-brain barrier.

Atropine is used to treat sinus bradycardia.

Scopolamine penetrates into the brain more readily compared to atropine.

Scopolamine is effective in preventing nausea and vomiting in motion sickness.

Scopolamine butylbromide has significant central nervous system effects.

Ipratropium is a short-acting muscarinic antagonist used for asthma treatment.

Tiotropium is a long-acting muscarinic antagonist used to treat chronic bronchitis and emphysema.

Cyclopentolate is used to produce miosis for diagnostic purposes.

Pirenzepine is an M1 selective antagonist used for peptic ulcer disease.

Cholinergic antagonists are ineffective in reducing gastrointestinal peristaltic activity.

Atropine competitively blocks the binding of acetylcholine to muscarinic receptors.

The dominant tone of the gastrointestinal tract is the sympathetic system.

Atropine is used as a pre-anesthetic medication to dry secretions.

Scopolamine butylbromide is poorly absorbed and lacks CNS effects.

Ipratropium and tiotropium are administered via inhalation.

Atropine is used in cases of organophosphate poisoning.

The effects of cholinergic antagonists are independent of the dominant tone of the affected organ.

Scopolamine blocks muscarinic receptors in the vomiting center to prevent motion sickness.

Tiotropium is a synthetic quaternary amine.